Sponsored by:

Nuclear Medicine: Page 368

Scintimammography-SPECT valid as secondary test for ambiguous breast cancer
By Shalmali Pal
Thus far, scintimammography's value has been proved in women with dense breasts or those who have breast cancer recurrence. Now researchers from Belgium have studied the impact of scintimammography in a clinical setting for women with inconclusive or contradictory results on routine breast imaging workup.
October 17, 2005
2005 09 27 16 01 15 706
Oncologic PET/CT: A primer for radiologists
AuntMinnie.com is pleased to present this white paper by Dr. Stephen Humes for our members to download. This primer is intended as a succinct guide to practicing radiologists for interpretation of oncologic PET/CT images, as well as a quick reference when consulting with referring physicians as to the appropriateness of performing PET/CT to address a specific clinical question.
October 13, 2005
Pdf Icon
Draxis taps Brazier as COO
Canadian pharmaceutical developer Draxis Health has named Dan Brazier as its chief operating officer (COO).
October 3, 2005
Nitrates enhance tetrofosmin SPECT viability capabilities
By Jonathan S. Batchelor
Establishing viable myocardial tissue is a crucial factor when considering patients with previous myocardial infarction and severe left ventricular dysfunction for coronary artery bypass grafting. A research team from Italy recently compared semiquantitative rest and postnitrate Tc-99m tetrofosmin SPECT with contrast-enhanced MRI (ceMRI) in detecting myocardial viability.
September 28, 2005
FDA issues draft CGMP for PET radiopharmaceuticals
By AuntMinnie.com staff writers
The Food and Drug Administration has drafted a current good manufacturing practices (CGMP) regulation for the production of pharmaceuticals used in PET imaging, the agency reported.
September 25, 2005
ECR offers molecular imaging grant
By AuntMinnie.com staff writers
The European Congress of Radiology (ECR) has announced the availability of a molecular imaging scholarship grant sponsored through the ECR/European Association of Radiology (EAR) research and education fund.
September 20, 2005
MDS Nordion to supply yttrium-90 to Berlex
By AuntMinnie.com staff writers
Canadian radioisotope developer MDS Nordion of Kanata, Ontario, has been selected by Berlex Canada to supply yttrium-90 chloride sterile solution (Y-90) for use with Berlex's Zevalin radioimmunotherapy indicated for non-Hodgkin's lymphoma (NHL).
September 19, 2005
Digirad names imaging services chief
Nuclear medicine vendor Digirad of Poway, CA, has hired Mark Casner as the new president of its Digirad Imaging Services equipment-leasing subsidiary.
September 15, 2005
Horak leaves Immunomedics
By AuntMinnie.com staff writers
Immunomedics executive vice president of research and development and chief scientific officer Dr. Ivan Horak has left the Morris Plains, NJ-based firm.
September 5, 2005
Setting up a solid PET/CT program takes planning and forethought
Adding new technology, such as a PET/CT program, can help bring in new customers and additional revenue. But careful planning and consideration are needed to help avoid major headaches and unanticipated problems.
September 1, 2005
Siemens logs 1,000th PET sale
By AuntMinnie.com staff writers
Multimodality vendor Siemens Medical Solutions announced the 1,000th installation of its PET technology this week.
August 30, 2005
CMS seeks to rein in nuclear medicine self-referral
By Jonathan S. Batchelor
The growth of nuclear medicine services in recent years has attracted the notice of the U.S. Centers for Medicare and Medicaid Services (CMS). This month, CMS proposed a rule barring physician self-referral for nuclear medicine procedures, raising more questions than answers.
August 30, 2005
Previous Page
Page 368 of 440
Next Page